BUSINESSTECHCRUNCH
Reed Jobs would rather talk about curing cancer than his last name
Reed Jobs focuses on advancing cancer cures through his venture firm Yosemite, which has grown from a new startup to a team of 17. The biotech industry faces patent expirations for blockbuster drugs, creating new opportunities, while AI has become a core part of Yosemite's operations. Jobs expressed surprise at the company's rapid progress.
Related Signal
Adjacent reporting
- China’s biotech firms challenge US with rapidly developing RAS-targeted cancer therapies
- STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
- Portal CEO on Lilly Deal for Cancer Biotech CrossBridge
- VC Ron Conway says he has a ‘rare form of cancer’
- STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more